Paeds Vivas · infectious-diseases
Hepatitis A, B, C and E in children — branching viva
Branching structured-oral viva on hepatitis A, B, C and E in children: the enteric-versus-blood-borne transmission and chronicity framework, serology and viral-load panels, the hepatitis A and E supportive pathway, the hepatitis B birth-dose-and-HBIG bundle and maternal tenofovir suppression, the hepatitis C test-and-treat pathway with direct-acting antivirals, chronic-carrier surveillance, and the acute liver failure bundle where INR is the prognostic anchor.
On this page
Study tools
Target exams
Opening question
Examiner: Take me through this child. What is the diagnosis, and what is your frame for managing her? [1]
Candidate: The leading diagnosis is acute hepatitis A — a returned traveller with the classic prodrome of fever and nausea, then dark urine and jaundice, transaminases in the thousands and a positive hepatitis A IgM, with a normal INR. My frame is to classify her on the two axes that matter: transmission route and chronicity. Hepatitis A is enteric and acute, so it clears without chronicity. The immediate priority is supportive care and the prevention of secondary spread; the prognostic anchor I watch is the INR, because a normal INR with this picture means severe hepatitis but not liver failure. [1]
Examiner: Why do you frame the four viruses by those two axes? [1]
Candidate: Because the two axes fix the whole approach. Transmission route tells me how the child met the virus — faecal-oral for A and E, blood-borne and perinatal for B and C — which frames the history, the contact tracing and the prevention. Chronicity tells me what happens next — A and E clear, while B and C persist when acquired neonatally. So a single framework, "faecal-oral is A and E, blood-borne and perinatal is B and C, and the chronic divide runs along the same line", organises the whole topic. [1] [6]
References7ShowHide
- [1]Van Damme P; Pintó RM; Feng Z; Cui F; et al Hepatitis A virus infection. Nat Rev Dis Primers, 2023.PMID 37770459
- [4]Cheung KW; Lao TT Hepatitis B - Vertical transmission and the prevention of mother-to-child transmission. Best Pract Res Clin Obstet Gynaecol, 2020.PMID 32249130
- [6]Indolfi G; Easterbrook P; Dusheiko G; Siberry G; et al Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol, 2019.PMID 30982722
- [9]Indolfi G; Serranti D; Resti M Direct-acting antivirals for children and adolescents with chronic hepatitis C. Lancet Child Adolesc Health, 2018.PMID 30169301
- [10]Bhattacharya D; Aronsohn A; Price J; Lo Re V; et al Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis, 2023.PMID 37229695
- [11]Verghese VP; Robinson JL A systematic review of hepatitis E virus infection in children. Clin Infect Dis, 2014.PMID 24846637
- [12]Bergløv A; Hallager S; Weis N Hepatitis E during pregnancy: Maternal and foetal case-fatality rates and adverse outcomes-A systematic review. J Viral Hepat, 2019.PMID 31095813